stars 1 stars 2 stars 3

Apollo Endosurgery, Inc. is a medical technology company focused on development of next-generation, less invasive devices to advance therapeutic endoscopy designed to treat a variety of gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, X-Tack TM Endoscopic HeliX Tacking System and the ORBERA® Intragastric Balloon.

Apollo Endosurgery Questions

The Apollo Endosurgery annual revenue was $76.9 million in 2026.

Christopher Gostout is the Chief Medical Officer of Apollo Endosurgery.

74 people are employed at Apollo Endosurgery.

Apollo Endosurgery is based in Austin, Texas.

The NAICS codes for Apollo Endosurgery are [33, 339].

The SIC codes for Apollo Endosurgery are [384, 38].

Top Apollo Endosurgery Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users